Oncology
An amino-terminal portion of the HCVNS3 protein has ties to liver cancer risk
Published in Cancer Weekly, September 9th, 2003
"The NS3 protein of hepatitis C virus subtype 1b (HCV-1b) isolates obtained from 89 patients with hepatocellular carcinoma (HCC) and 78 patients without HCC were analyzed. On the basis of the secondary structure of the amino-terminal 120 residues of NS3, HCV-1b isolates were classified into group A, group B, and an indeterminate group, each of which was further divided into a number of subgroups, such as A1-1, A1-2, A2-1, A2-2, B1-1, B1-2, B2-1, B2-2, C-1, C-2, and C-3," according to scientists in Japan.
"HCV-1b isolates of subgroup B1-1 were found in 53 (59.6%) of 89...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-09)
More Articles from Cancer Weekly
- Breast Cancer
Dose reduction is feasible for full-field digital mammography - Prostate Cancer
New method using readily accessible data predicts disease prior to biopsy - Biological Therapy
Carbonic anhydrases may inhibit tumor growth and invasion - Brain Cancer
New treatment extends survival for more patients - Colorectal Cancer
Folate and alcohol may be associated with changes in promoter hypermethylation - HIV/AIDS Cancer
CD28 and ligands involved in AIDS- and EBV-associated lymphoma development - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
